- Home
- CLLS vs OXSQ Comparison
CLLS vs OXSQ Comparison
Compare CLLS & OXSQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLLS
- OXSQ
- Stock Information
- Founded
- CLLS 1999
- OXSQ 2003
- Country
- CLLS France
- OXSQ United States
- Employees
- CLLS N/A
- OXSQ N/A
- Industry
- CLLS Biotechnology: Pharmaceutical Preparations
- OXSQ Blank Checks
- Sector
- CLLS Health Care
- OXSQ Finance
- Exchange
- CLLS Nasdaq
- OXSQ Nasdaq
- Market Cap
- CLLS 143.4M
- OXSQ 164.9M
- IPO Year
- CLLS 2007
- OXSQ N/A
- Fundamental
- Price
- CLLS $1.59
- OXSQ $2.28
- Analyst Decision
- CLLS Buy
- OXSQ
- Analyst Count
- CLLS 1
- OXSQ 0
- Target Price
- CLLS $4.00
- OXSQ N/A
- AVG Volume (30 Days)
- CLLS 48.2K
- OXSQ 614.2K
- Earning Date
- CLLS 08-05-2025
- OXSQ 08-12-2025
- Dividend Yield
- CLLS N/A
- OXSQ 18.38%
- EPS Growth
- CLLS N/A
- OXSQ N/A
- EPS
- CLLS N/A
- OXSQ N/A
- Revenue
- CLLS $54,747,000.00
- OXSQ $42,166,831.00
- Revenue This Year
- CLLS $48.52
- OXSQ N/A
- Revenue Next Year
- CLLS $5.17
- OXSQ N/A
- P/E Ratio
- CLLS N/A
- OXSQ N/A
- Revenue Growth
- CLLS 351.26
- OXSQ N/A
- 52 Week Low
- CLLS $1.10
- OXSQ $2.14
- 52 Week High
- CLLS $2.43
- OXSQ $3.10
- Technical
- Relative Strength Index (RSI)
- CLLS 56.98
- OXSQ 49.98
- Support Level
- CLLS $1.56
- OXSQ $2.14
- Resistance Level
- CLLS $1.49
- OXSQ $2.32
- Average True Range (ATR)
- CLLS 0.09
- OXSQ 0.03
- MACD
- CLLS 0.01
- OXSQ 0.01
- Stochastic Oscillator
- CLLS 80.00
- OXSQ 77.78
About CLLS Cellectis S.A.
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.
About OXSQ Oxford Square Capital Corp.
Oxford Square Capital Corp is a closed-end, non-diversified management investment company with a focus is to seek an attractive risk-adjusted total return by investing in corporate debt securities and collateralized loan obligation (CLO) structured finance investments that own corporate debt securities. its capital is generally used by its corporate borrowers to finance organic growth, acquisitions, recapitalizations, and working capital. The group invests in various industries such as Structured Finance, IT Consulting, Business Services, Utilities, Software, Healthcare, Telecommunication Services, Plastics Manufacturing and Diversified Insurance.